AARTI DRUGS
Back to Cashflow Statement
|
AARTI DRUGS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-0.76 Cr | ₹-14 Cr | ₹13 Cr | ₹2.04 Cr | ₹2.13 Cr |
What is the latest Net Cash Inflow / Outflow ratio of AARTI DRUGS ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹-0.76 Cr |
Mar2023 | ₹-14 Cr |
Mar2022 | ₹13 Cr |
Mar2021 | ₹2.04 Cr |
Mar2020 | ₹2.13 Cr |
How is Net Cash Inflow / Outflow of AARTI DRUGS Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹-0.76 Cr | Negative | |
Mar2023 | ₹-14 Cr | Negative | |
Mar2022 | ₹13 Cr | 526.79 | |
Mar2021 | ₹2.04 Cr | -4.04 | |
Mar2020 | ₹2.13 Cr | - |
Compare Net Cash Inflow / Outflow of peers of AARTI DRUGS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI DRUGS | ₹4,813.8 Cr | -1.7% | 16.4% | 2.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,595.0 Cr | 1.5% | 0.9% | 2% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,635.0 Cr | -0.5% | -1.2% | 45.5% | Stock Analytics | |
CIPLA | ₹126,894.0 Cr | 7.2% | 4.5% | 2.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,685.0 Cr | 3.5% | 8.4% | 16.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,373.0 Cr | 3.7% | -1.1% | -6.8% | Stock Analytics |
AARTI DRUGS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI DRUGS | -1.7% |
16.4% |
2.4% |
SENSEX | -1.6% |
-3.4% |
0.9% |
You may also like the below Video Courses